25 participants
Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-09-02
- Start Date:
- 2026-09-30
- Completion:
- 2028-06-30
Conditions
- IDH1 Mutation
- Relapsed / Refractory AML
Interventions
- DRUG
No Results Yet